Gadolinium-based bimodal probes to enhance T1-Weighted magnetic resonance/optical imaging. (1st July 2020)
- Record Type:
- Journal Article
- Title:
- Gadolinium-based bimodal probes to enhance T1-Weighted magnetic resonance/optical imaging. (1st July 2020)
- Main Title:
- Gadolinium-based bimodal probes to enhance T1-Weighted magnetic resonance/optical imaging
- Authors:
- Yang, Chang-Tong
Hattiholi, Aishwarya
Selvan, Subramanian Tamil
Yan, Sean Xuexian
Fang, Wei-Wei
Chandrasekharan, Prashant
Koteswaraiah, Podili
Herold, Christian J.
Gulyás, Balázs
Aw, Swee Eng
He, Tao
Ng, David Chee Eng
Padmanabhan, Parasuraman - Abstract:
- Abstract: Gd 3+ -based contrast agents have been extensively used for signal enhancement of T1 -weighted magnetic resonance imaging (MRI) due to the large magnetic moment and long electron spin relaxation time of the paramagnetic Gd 3+ ion. The key requisites for the development of Gd 3+ -based contrast agents are their relaxivities and stabilities which can be achieved by chemical modifications. These modifications include coordinating Gd 3+ with a chelator such as diethylenetriamine pentaacetic acid (DTPA) or 1, 4, 7, 10-Tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid (DOTA), encapsulating Gd 3+ in nanoparticles, conjugation to biomacromolecules such as polymer micelles and liposomes, or non-covalent binding to plasma proteins. In order to have a coherent diagnostic and therapeutic approach and to understand diseases better, the combination of MRI and optical imaging (OI) techniques into one technique entity has been developed to overcome the conventional boundaries of either imaging modality used alone through bringing the excellent spatial resolution of MRI and high sensitivity of OI into full play. Novel MRI and OI bimodal probes have been extensively studied in this regard. This review is an attempt to shed some light on the bimodal imaging probes by summarizing all recent noteworthy publications involving Gd 3+ containing MR-optical imaging probes. The several key elements such as novel synthetic strategy, high sensitivity, biocompatibility, and targeting of theAbstract: Gd 3+ -based contrast agents have been extensively used for signal enhancement of T1 -weighted magnetic resonance imaging (MRI) due to the large magnetic moment and long electron spin relaxation time of the paramagnetic Gd 3+ ion. The key requisites for the development of Gd 3+ -based contrast agents are their relaxivities and stabilities which can be achieved by chemical modifications. These modifications include coordinating Gd 3+ with a chelator such as diethylenetriamine pentaacetic acid (DTPA) or 1, 4, 7, 10-Tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid (DOTA), encapsulating Gd 3+ in nanoparticles, conjugation to biomacromolecules such as polymer micelles and liposomes, or non-covalent binding to plasma proteins. In order to have a coherent diagnostic and therapeutic approach and to understand diseases better, the combination of MRI and optical imaging (OI) techniques into one technique entity has been developed to overcome the conventional boundaries of either imaging modality used alone through bringing the excellent spatial resolution of MRI and high sensitivity of OI into full play. Novel MRI and OI bimodal probes have been extensively studied in this regard. This review is an attempt to shed some light on the bimodal imaging probes by summarizing all recent noteworthy publications involving Gd 3+ containing MR-optical imaging probes. The several key elements such as novel synthetic strategy, high sensitivity, biocompatibility, and targeting of the probes are highlighted in the review. Statement of Significance: The present article aims at giving an overview of the existing bimodal MRI and OI imaging probes. The review structured as a series of examples of paramagnetic Gd 3+ ions, either as ions in the crystalline structure of inorganic materials or chelates for contrast enhancement in MRI, while they are used as optical imaging probes in different modes. The comprehensive review focusing on the synthetic strategies, characterizations and properties of these bimodal imaging probes will be helpful in a way to prepare related work. Graphic abstract: Image, graphical abstract … (more)
- Is Part Of:
- Acta biomaterialia. Volume 110(2020)
- Journal:
- Acta biomaterialia
- Issue:
- Volume 110(2020)
- Issue Display:
- Volume 110, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 110
- Issue:
- 2020
- Issue Sort Value:
- 2020-0110-2020-0000
- Page Start:
- 15
- Page End:
- 36
- Publication Date:
- 2020-07-01
- Subjects:
- Bimodality imaging probe -- MRI -- Optical imaging -- Contrast agent -- Nanomaterials
Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://www.sciencedirect.com/science/journal/17427061 ↗
http://www.elsevier.com/wps/find/journaldescription.cws%5Fhome/702994/description ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.actbio.2020.03.047 ↗
- Languages:
- English
- ISSNs:
- 1742-7061
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0602.900500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25838.xml